Product
Help
Pricing
About
Jobs
Log in
Get started
Work
Add to collection
CYP17 inhibitors for prostate cancer therapy
HTML
Details
Locations
Year:
2010
Type:
review
Source:
The Journal of Steroid Biochemistry and Molecular Biology
DOI:
10.1016/j.jsbmb.2010.11.005
Authors:
Tadas S. Vasaitis,
Robert D. Bruno,
Vincent C.O. Njar
Institutions:
University of Maryland, Baltimore,
University of Maryland Eastern Shore,
National Cancer Institute,
Center for Cancer Research,
Thomas Jefferson University,
Sidney Kimmel Cancer Center
show all 6
Language:
English
Topic:
Prostate Cancer Treatment and Research
Subfield:
Cancer Research
Field:
Biochemistry, Genetics and Molecular Biology
Domain:
Life Sciences
SDG:
Good health and well-being
Open Access status:
green
Funders:
Thomas Jefferson University,
National Institutes of Health,
National Institute on Aging,
National Cancer Institute
Awards:
The Biology of Exercise, Metabolism and Aging,
G5805250173,
Retinoids, RAMBAs, and Histone Deacetylase Inhibitors
OpenAlex ID:
W1969952491
FWCI:
1.152
Cites:
91
Cited by:
221
Related to:
9